Strategic Medical Affairs and Regulatory Expertise for Pharma, Biotech, and MedTech.

On Precision Medicine
Salience Clinical’s expertise in biomarker-driven enrichment fundamentally changed our program. By integrating multimodal plasma biomarkers with PET imaging, they transformed a noisy, data-heavy development landscape into a clear clinical strategy. Their work enabled us to move beyond cognitive symptoms and anchor our program in biological evidence of disease.

On Regulatory Execution
During our most complex health authority interactions, Salience Clinical became our strategic anchor. As our principal clinical strategist, they authored core sections of our regulatory submissions and served as our primary interface with FDA and EMA. Their ability to cut through ambiguity and isolate what truly matters for approval is rare.

On Complex Modalities
Cell-based and biologics programs carry exceptional scientific and regulatory risk. Salience Clinical provided the senior-level leadership required to successfully direct our global Phase III program. Their experience with living products and regenerative medicine strategy was instrumental in keeping our development pathway both rigorous and viable.